Table 1 Baseline characteristics of patients receiving thrombolytic treatment in mothership, drip-and-ship, and ship-and-drip paradigms
Overall (n = 273) | Mothership (n = 147) | Drip-and-Ship (n = 87) | Ship-and-Drip (n = 39) | P value | |
|---|---|---|---|---|---|
Age, med (IQR) | 66 (22) | 68 (22) | 64 (22) | 60 (29) | 0.22 |
Female, n (%) | 123 (45.1%) | 71 (48.3%) | 34 (39.1%) | 18 (46.2%) | 0.39 |
Initial NIHSS, med (IQR) | 10 (11) | 8 (10) | 11 (13) | 12 (12) | 0.18 |
Risk factors, n (%) | |||||
- Hypertension | 160 (58.6%) | 84 (57.1%) | 50 (57.5%) | 26 (66.7%) | 0.54 |
- Diabetes mellitus | 71 (26.0%) | 36 (24.5%) | 23 (26.4%) | 12 (30.8%) | 0.73 |
- Dyslipidemia | 99 (36.3%) | 58 (39.5%) | 24 (27.6%) | 17 (43.6%) | 0.11 |
- History of stroke | 42 (15.4%) | 28 (19.0%) | 11 (12.6%) | 3 (7.7%) | 0.15 |
- History of myocardial infarction | 25 (9.2%) | 17 (11.6%) | 6 (6.9%) | 2 (5.1%) | 0.31 |
Underlying malignancy | 19 (7.0%) | 15 (10.2%) | 2 (2.3%) | 2 (5.1%) | 0.06 |
Stroke subtypes, n (%) | 0.07 | ||||
- Large vessel | 38 (13.9%) | 17 (11.6%) | 20 (23.0%) | 1 (2.6%) | |
- Small vessel | 55 (20.1%) | 34 (23.1%) | 15 (17.2%) | 6 (15.4%) | |
- Cardioembolic | 99 (36.3%) | 52 (35.4%) | 29 (33.3%) | 18 (46.2%) | |
- Other determined | 2 (0.7%) | 2 (1.4%) | 0 (0%) | 0 (0%) | |
- Undetermined | 79 (28.9%) | 42 (28.6%) | 23 (26.4%) | 14 (35.9%) | |
Thrombectomy | 24 (8.8%) | 13 (8.8%) | 10 (11.5%) | 1 (2.6%) | 0.26 |